Influence of endogenous NEFA on beta cell function in humans

Diabetologia

Volumn 58, Issue 10, 2015, Pages 2344-2351

  Rebelos, Eleni ^a   Seghieri, Marta ^a   Natali, Andrea ^a   Balkau, Beverly ^b   Golay, Alain ^c   Piatti, Pier Marco ^d   Lalic, Nebojsa M ^e   Laakso, Markku ^f   Mari, Andrea ^g   Ferrannini, Ele ^a,h  

^a UNIVERSITY OF PISA   (Italy)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF BELGRADE   (Serbia)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g CNR   (Italy)

^h INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Beta cell function; Beta cell glucose sensitivity; Glucose intolerance; Insulin resistance; Lipotoxicity; NEFA

Indexed keywords

FATTY ACID; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ARTICLE; DIET RESTRICTION; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIPOTOXICITY; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; ANALYSIS; BLOOD; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED;

EID: 84942124504     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3685-6     Document Type: Article

References (37)

1. Ferrannini E, Camastra S, Coppack SW, Fliser D, Golay A, Mitrakou A (1997) Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR). Proc Nutr Soc 56:753–761
2. Lafontan M, Langin D (2009) Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 48:275–797
3. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–789
4. Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267–2277
5. Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44:863–870
6. Briaud I, Harmon JS, Kelpe CL, Segu VB, Poitout V (2001) Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 50:315–321
7. McGarry JD (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7–18
8. Warnotte C, Gilon P, Nenquin M, Henquin JC (1994) Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes 43:703–711
9. Zhou YP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870–876
10. Elks ML (1993) Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology 133:208–214
11. Stein DT, Esser V, Stevenson BE et al (1996) Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728–2735
12. Sako Y, Grill VE (1990) A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127:1580–1589
13. Mason TM, Goh T, Tchipashvili V et al (1999) Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48:524–530
14. Boden G, Chen X, Rosner J, Barton M (1995) Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239–1242
15. Boden G, Chen X (1999) Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. Diabetes 48:577–583
16. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276:E1055–E1066
17. Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF (2000) Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49:399–408
18. Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461–2474
19. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E (1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213–1217
20. Stefan N, Stumvoll M, Bogardus C, Tataranni PA (2003) Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT. Am J Physiol Endocrinol Metab 284:E1156–E1161
21. Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566–570
22. Ferrannini E, Balkau B, Coppack SW et al (2007) Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 92:2885–2892
23. Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl 1):S221–S226
24. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166
25. Mari A, Ferrannini E (2008) Beta-cell function assessment from modelling of oral tests: an effective approach. Diabetes Obes Metab 10(Suppl 4):S77–S87
26. Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377
27. Stefanovski D, Richey JM, Woolcott O et al (2011) Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA. PLoS One 6:e18134
28. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA (1991) The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72:96–107
29. Groop LC, Bonadonna RC, DelPrato S et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 84:205–213
30. Santomauro AT, Boden G, Silva ME et al (1999) Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48:1836–1841
31. Karpe F, Dickmann JR, Frayn KN (2011) Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60:2441–2449
32. Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT (1998) Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 7:1613–1618
33. Santini E, Fallahi P, Ferrari SM, Masoni A, Antonelli A, Ferrannini E (2004) Effect of PPAR-gamma activation and inhibition on glucose-stimulated insulin release in INS-1e cells. Diabetes 53(Suppl 3):S79–S83
34. Hellmuth C, Demmelmair H, Schmitt I, Peissner W, Bluher M, Koletzko B (2013) Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PLoS One 8:e74927
35. Byrne CD, Maison P, Halsall D, Martensz N, Hales CN, Wareham NJ (1999) Cross-sectional but not longitudinal associations between non-esterified fatty acid levels and glucose intolerance and other features of the metabolic syndrome. Diabet Med 16:1007–1015
36. Salgin B, Ong KK, Thankamony A, Emmett P, Wareham NJ, Dunger DB (2012) Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes. J Clin Endocrinol Metab 97:3302–3309
37. Gillum MP, Zhang D, Zhang XM et al (2008) N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake. Cell 135:813–824